198 related articles for article (PubMed ID: 23905598)
1. The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.
Faselis C; Doumas M; Kokkinos P; Tsioufis C; Papademetriou V
Curr Vasc Pharmacol; 2014 Jan; 12(1):38-46. PubMed ID: 23905598
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
[TBL] [Abstract][Full Text] [Related]
3. Current technologies: an introduction.
Daemen J
EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
[No Abstract] [Full Text] [Related]
4. Challenging anatomy, how to treat or not to treat?
Zeller T; Rastan A; Macharzina R; Noory E
EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
[TBL] [Abstract][Full Text] [Related]
5. Renal nerve ablation for hypertensive patients with chronic kidney disease.
Papademetriou V; Doumas M; Anyfanti P; Faselis C; Kokkinos P; Tsioufis C
Curr Vasc Pharmacol; 2014 Jan; 12(1):47-54. PubMed ID: 23905594
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
Ewen S; Ukena C; Böhm M; Mahfoud F
Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
[No Abstract] [Full Text] [Related]
7. [Radiofrequency sympathetic renal denervation: a new version of the old method of treatment resistant hypertension].
Shavarov AA; Maĭskov VV; Kobalava ZhD
Kardiologiia; 2013; 53(1):72-8. PubMed ID: 23548354
[No Abstract] [Full Text] [Related]
8. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
9. [Renal denervation - a novel therapeutic option for resistant hypertension?].
Ritter A; Sudano Noll I; Suter PM
Praxis (Bern 1994); 2014 Oct; 103(20):1169-78. PubMed ID: 25270745
[No Abstract] [Full Text] [Related]
10. What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.
Schlaich MP
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1267-F1270. PubMed ID: 27630063
[TBL] [Abstract][Full Text] [Related]
11. Peri-procedural care of renal nerve ablation candidates.
Tsioufis C; Dimitriadis K; Thomopoulos C; Tsiachris D; Kasiakogias A; Kintis K; Flesas D; Papademetriou V; Stefanadis C
Curr Clin Pharmacol; 2013 Aug; 8(3):217-23. PubMed ID: 23173966
[TBL] [Abstract][Full Text] [Related]
12. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
13. [Renal sympathetic denervation in refractory hypertension].
Sans Atxer L; Oliveras A
Med Clin (Barc); 2013 Mar; 140(6):263-5. PubMed ID: 23276614
[No Abstract] [Full Text] [Related]
14. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.
Ammar S; Ladich E; Steigerwald K; Deisenhofer I; Joner M
EuroIntervention; 2013 May; 9 Suppl R():R89-95. PubMed ID: 23732162
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Voora R; Hinderliter AL
Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
[TBL] [Abstract][Full Text] [Related]
17. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
Laffin LJ; Bakris GL
Am J Hypertens; 2017 Sep; 30(9):841-846. PubMed ID: 27838622
[TBL] [Abstract][Full Text] [Related]
18. The future of interventional management of hypertension: threats and opportunities.
Briasoulis A; Bakris G
Curr Vasc Pharmacol; 2014 Jan; 12(1):69-76. PubMed ID: 23905592
[TBL] [Abstract][Full Text] [Related]
19. Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
Lüscher TF; Mahfoud F
Eur Heart J; 2014 Jul; 35(26):1706-11. PubMed ID: 24829361
[No Abstract] [Full Text] [Related]
20. Renal sympathetic denervation in hypertension.
Doumas M; Faselis C; Papademetriou V
Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
